longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Dencare

001328

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 25.45, below the reasonable range, cheaper than 95.77% of the time in the past 3 years, and the industry ranks 10/27, the industry Median 23.94.

25.45xP/E
¥29.16Stock price
¥1.15Earnings per share
25.45xP/E
Stock price¥29.16Earnings per share¥1.15

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
35.50x
Typical range
28.80x–42.76x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.94x
019385776

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.94x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
300146SZBYHEALTH
24.22x9.67%¥15.72B
603868SHFLYCO
23.94x19.07%¥13.18B
300957SZBTN
23.82x24.60%¥13.12B
603193SHRunben Biotechnology
22.00x19.23%¥7.74B
605009SHHaoyue Care
21.69x21.30%¥5.15B
001328SZDencare
25.45x19.36%¥5.02B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.